Dietary Supplements Access Act
Summary
HR8933 (Dietary Supplements Access Act) is an early-stage bill that would allow up to $500/year in dietary supplement purchases to be treated as qualified medical expenses for HSAs, FSAs, and HRAs, retroactive to 2026. The bill has no direct government spending and does not change regulatory requirements for supplement manufacturers. Supplements are NOT pre-tax eligible today for HSAs/FSAs. This bill would expand the addressable market by making supplements purchasable with pre-tax dollars for ~70 million HSA/FSA account holders. However, it does not mandate that health plans cover supplements or require any company to change its behavior. The bill has been referred to the House Ways & Means Committee and has a companion bill in the Senate (S4587).
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.HR8933 would let HSA/FSA dollars buy up to $500/year in supplements, effective retroactively to 2026.
- 2.No direct government spending — tax expenditure only. No regulatory changes for supplement makers.
- 3.Modest demand driver for $NUS, $HLF, $USNA but unlikely to materially change revenue trajectory. Energy drink exclusion protects supplement pure-plays from beverage competition.
- 4.Early-stage bill with long legislative path ahead. Companion bill in Senate improves but does not guarantee passage.
Market Implications
The bill is too early-stage and small in impact to drive any measurable stock movement. Supplement stocks ($NUS, $HLF, $USNA) are driven by revenue growth, MLM distributor metrics, and debt profiles — not a ~$200 annual tax savings per HSA user. Monitor for Ways and Means markup as a catalyst. If attached to a must-pass tax bill, probability rises. As a stand-alone, likely DOA. No price data available — do not fabricate.
Full Analysis
-
On May 20, 2026, Rep. LaHood (R-IL) introduced HR8933, the Dietary Supplements Access Act. The bill was referred to the House Ways and Means Committee, the tax-writing committee. It has three cosponsors (one Democrat, two Republicans) and an identical companion bill (S4587) in the Senate referred to the Finance Committee. The bill is early-stage — it has taken no further legislative action beyond introduction and referral.
-
The bill operates through tax code amendments — it does NOT authorize or appropriate any government spending. It amends Sections 223 (HSAs), 220 (Archer MSAs), and 106 (FSAs/HRAs) of the Internal Revenue Code to include dietary supplements (defined per FDA 21 U.S.C. 321(ff), explicitly excluding energy drinks, soft drinks, and sodas) as qualified medical expenses up to $500/year ($250 MFS). The effective date is retroactive to December 31, 2025. This means 2026 tax-year contributions can already be used for supplements if the bill passes. The budgetary impact is reduced tax revenue (estimated small because HSA/FSA dollars are pre-tax either way — the bill just expands what they can buy).
-
This bill is a modest positive for supplement manufacturers but unlikely to move share prices measurably. Pure-play publicly traded supplement companies include Nu Skin Enterprises ($NUS), Herbalife ($HLF), and USANA Health Sciences ($USNA). The mechanism is consumer behavior change — supplements become 22-37% cheaper for the ~70 million Americans with HSAs (2025 figure) and the much larger FSA user base. However, HSA/FSA account balances are not new money — they are pre-tax dollars already set aside for medical expenses. This bill lets existing dollars buy supplements rather than other qualified expenses (co-pays, prescriptions, dental). The net new demand for supplements is likely modest. The bill explicitly excludes energy drinks, which protects traditional supplement manufacturers from competition from beverage companies ($CELH, $KDP).
-
No REAL MARKET DATA available on supplement stock performance. The broader supplement industry is ~$55B in the US (2025) with ~3% annual growth. This bill could add 0.5-1% to industry revenue in the first year, concentrated in the HSA/FSA channel.
-
Timeline: This is early-stage legislation with a narrow tax benefit. Passage probability rises if it gets included in a tax extenders package (likely in 2026-2027) but faces long odds as a stand-alone bill given the crowded 119th Congress calendar. The House Ways and Means Committee markup is the next milestone. If no markup by Sept 2026, the bill likely dies. Companion bill in Senate Finance provides a parallel path.
Intelligence Surface
Cross-referenced against federal contracts, SEC insider filings & congressional trade disclosures
No confirming evidence found yet from contracts, insider trades, or congressional activity
What the bill does
Tax Code amendment: Dietary supplements up to $500/year become qualified medical expenses for HSAs, FSAs, HRAs (retroactive to 2025). No change in FDA regulatory status or sales legality. No government procurement or subsidy.
Who must act
Individual taxpayers with HSA/FSA/HRA accounts who purchase dietary supplements. IRS must update Publication 502. Supplement manufacturers see no direct compliance cost change.
What happens
Up to $500/year in supplement purchases per HSA/FSA-eligible individual become pre-tax. This effectively provides a ~22-37% price discount (marginal federal income tax bracket) for those using tax-advantaged accounts. Addressable market expands by the HSA/FSA user base (~70M Americans) times average annual supplement spend (~$150-300). No revenue accrues to manufacturers; it is a consumer tax benefit.
Stock impact
Nu Skin sells premium-priced nutritional supplements via direct sales. Pre-tax purchasing reduces effective consumer out-of-pocket cost, potentially boosting unit volume modestly. However, most HSA/FSA users already overspend their accounts on qualified medical costs; this redirects existing account dollars rather than creating new demand. Nu Skin's 2025 revenue is ~$1.7B; estimated incremental revenue from this policy <1%.
What the bill does
Same tax code amendment as above: supplements become pre-tax HSA/FSA eligible up to $500/year.
Who must act
Individual HSA/FSA account holders purchasing supplements.
What happens
Same consumer price reduction as above. Herbalife's revenue model is MLM-based nutrition supplements. Pre-tax status for supplements is a marginal positive for consumer demand but does not change Herbalife's FTC consent decree, distributor attrition, or debt structure.
Stock impact
Herbalife's 2025 revenue ~$5.0B. Modest incremental demand from FSA/HSA eligibility. Likely immaterial to overall financials. Competitively neutral — all supplement companies get same benefit.
Key Legislators
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
Dietary Supplements Access Act
Dietary Supplement Listing Act of 2026
HSA’s For All Act
Flexible Savings Arrangements for a Healthy Robust America Act
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Delivering Gold Standard Childhood Vaccine Recommendations for Americans
This executive order directs HHS to establish a 'Gold Standard' childhood vaccine schedule with fewer recommended vaccines than current CDC guidelines, mandates that MMR be administered as three separate single-disease shots when domestically available, and instructs the DOJ to challenge state vaccine mandates that do not provide religious or medical exemptions. It also orders HHS to develop alternative adjuvants to aluminum and improve vaccine safety monitoring, while preserving access to existing vaccines.
Continuing to Protect the Meaning and Value of American Citizenship
This executive order directs federal agencies, including State, Justice, Homeland Security, and Social Security, to deny U.S. citizenship documentation to children born in the U.S. whose parents include alien enemies, foreign government employees, or those involved in commercial birth tourism or surrogacy, or who are born in territories without statutory citizenship. It implements a narrow interpretation of the Fourteenth Amendment following the Supreme Court's decision in Trump v. Barbara, effectively restricting birthright citizenship for specific categories of non-citizen parents.
Ending Birth Tourism
This executive order directs the Secretaries of State and Homeland Security to prevent foreign nationals from entering the U.S. on nonimmigrant visas for the purpose of giving birth (birth tourism), including revoking visas, barring entry, and taking action against facilitators. It defines birth tourism as entry via nonimmigrant visa for childbirth and allows humanitarian or national interest exemptions.
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →